Table 1

Frequency of LOH and LOI for IGF2 and H19 in 43 ovarian cancers

Frequency, no. (%)
HeterozygousLOHLOIa
IGF2 ApaI site24 (55.8)4 (16.7)5 (25)
H19 RsaI site20 (46.5)3 (15)4 (23.5)
H19 AluI site16 (37.2)1 (6.3)1 (6.7)
  • a Percentage of LOI in cancer with no LOH.